This study aimed to investigate the effects of Tecar therapy on pain, physical function, and physical capacity in patients with chronic knee osteoarthritis.
Who can participate
Age range40 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients with Kellgren-Lawrence stage 2 or 3 knee osteoarthritis
* Patients with bilateral knee pain for at least 6 weeks
* Male and female patients aged 40-75
* Patients who accept and sign the informed consent form
Exclusion Criteria:
* Those who have received physical therapy for knee pain in the last 6 months
* Those who have received intraarticular injection treatments such as hyaluronic acid, PRP, or steroids for knee pain in the last 6 months
* Those who have undergone knee surgery for any reason
* Those with inflammatory arthritis
* Those with existing neurological, cognitive, or psychiatric disorders
* Those with pacemakers
* Those with a history of malignancy
* Those with local vascular or sensory impairment
* Those with local or systemic infections
* Those with open wounds on the skin
* Pregnant or breastfeeding